Chronic Treatment of Syrian Hamsters With Low-Dose Selegiline Increases Life Span in Females But Not Males
- 30 April 1997
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 18 (2) , 205-211
- https://doi.org/10.1016/s0197-4580(97)00009-2
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- (−)Deprenyl and (−)1-phenyl-2-propylaminopentane, [(−) PPAP] act primarily as potent stimulants of action potential — transmitter release coupling in the catecholaminergic neuronsLife Sciences, 1996
- High performing rats are more sensitive toward catecholaminergic activity enhancer (CAE) compounds than their low performing peersLife Sciences, 1996
- Lack of protective effect of R(-)-deprenyl on programmed cell death of mouse thymocytes induced by dexamethasoneLife Sciences, 1995
- Sexually low performing male rats die earlier than their high performing peers and (-)deprenyl treatment eliminates this differenceLife Sciences, 1994
- Age-related memory decline and longevity under treatment with selegilineLife Sciences, 1994
- Sex-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine treatment may be related to differences in monoamine oxidase BNeuroscience Letters, 1994
- Chronic treatment of (-)deprenyl prolongs the life span of male fischer 344 rats. Further evidenceLife Sciences, 1993
- The effect of long-term treatment with deprenyl on basal and L-DOPA evoked dopamine release in vitro from the corpus striatum of aged ratsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1991
- The effect of age on the activity and molecular properties of human brain monoamine oxidaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1980
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1975